The National Institutes of Health (NIH) is offering the Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) to enhance the research workforce in non-malignant kidney, urologic, and hematologic diseases. This funding opportunity invites applications for U2C-TL1 awards aimed at recruiting, training, and retaining researchers by providing coordinated support, resources, and networks, with a focus on establishing an Administrative Core, a Networking and Professional Development Core, and a TL1 Training Core that supports at least five pre- and/or post-doctoral trainees. The total estimated program funding is $4 million, with individual awards capped at $2.1 million, and applications are due by May 25, 2026, and May 25, 2027, with the final closing date for submissions set for May 26, 2028. For further inquiries, interested applicants can contact Tracy Rankin, Ph.D., at NIDDK_KUH@nih.gov.

PAR-26-115-Full-Announcement.html

The Department of Health and Human Services, National Institutes of Health, and National Institute of Diabetes and Digestive and Kidney Diseases have reissued PAR-23-248 as PAR-26-115, an Institutional Network Award (U2C - Clinical Trial Not Allowed). This funding opportunity, titled "Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training," aims to bolster the research workforce in non-malignant kidney, urologic, and hematologic diseases. It invites applications for U2C-TL1 awards to recruit, train, and retain researchers by providing coordinated support, resources, and networks. The awards will establish an Administrative Core (U2C), a Networking and Professional Development Core (U2C), and a TL1 Training Core, which must support at least five pre- and/or post-doctoral trainees. The U2C costs cannot exceed 40% of the TL1 costs. Eligible applicants include various higher education institutions, nonprofits, and government entities, with a maximum project period of five years. Applications are due May 25, 2026, and May 25, 2027, with an expiration date of May 26, 2028.

Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has incorporated additional flexibilities for institutional training programs serving the mission interests of non-malignant kidney, urologic, and hematologic diseases, encompassing both adult and pediatric conditions. The purpose of this notice of funding opportunity is to invite applications for Institutional Network Awards (U2C-TL1) to recruit, train, and retain the next generation of researchers and provide them with the coordinated support, resources, and networks they need to succeed and lead. To maximize integration and promote a highly connected trainee community, institutions are invited to submit a single, unified U2C-TL1 application. Representation across all kidney, urologic, and hematologic disciplines is not expected or required. If feasible, applications may include multiple departments within and across institutions. It is expected that each U2C-TL1 award will actively participate in the Kidney, Urology and Hematology Research-Training Network (KUHR-TN), a nationwide coalition of individual U2C-TL1 awards.

Tracy Rankin, Ph.D.&lt;br/&gt;NIDDK_KUH@nih.gov

Buyer

Award Range

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source